LCM
DXCM icon

Logan Capital Management’s DexCom DXCM Stock Holding History

Logan Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-312
Closed -$23K – 510
2022
Q2 		$23K Hold
312
– – ﹤0.01% 392
2022
Q1 		$40K Hold
312
– – ﹤0.01% 372
2021
Q4 		$42K Hold
312
– – ﹤0.01% 375
2021
Q3 		$43K Buy
312
+136
+77% +$17.2K ﹤0.01% 368
2021
Q2 		$19K Buy
+176
New +$16.9K ﹤0.01% 420

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Logan Capital Management's DXCM Position: Q3 2022 in Review

Logan Capital Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 312 shares — an estimated $23K sold.

Logan Capital Management first reported a position in DXCM in Q2 2021 and held it in 5 quarters. The position peaked at $43K in Q3 2021. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Logan Capital Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Logan Capital Management sold 312 DexCom shares in Q3 2022, an estimated $23K.
  • Logan Capital Management first reported a position in DexCom in Q2 2021 and held it in 5 quarters.
  • Logan Capital Management's DexCom position peaked at $43K in Q3 2021.
  • 794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Logan Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.